Literature DB >> 15289619

Coactivator AIB1 links estrogen receptor transcriptional activity and stability.

Wenlin Shao1, Erika Krasnickas Keeton, Donald P McDonnell, Myles Brown.   

Abstract

Agonist-mediated degradation of estrogen receptor alpha (ERalpha) has been associated with its transcriptional activity. However, the mechanism by which ERalpha is targeted for degradation and whether there is a direct functional link between ERalpha stability and ERalpha-mediated transactivation have not been elucidated. Here we provide evidence that the p160 coactivator, AIB1, uniquely mediates agonist-induced, but not antagonist-induced, ERalpha degradation. We show that AIB1 recruitment by ERalpha is not only necessary but also sufficient to promote degradation. Suppression of AIB1 levels leads to ERalpha stabilization in the presence of 17beta-estradiol and, despite increased ERalpha levels, reduced recruitment of ERalpha to endogenous target gene promoters. In addition, association of RNA polymerase II with ERalpha target promoters is lost when AIB1 is suppressed, leading to inhibition of target gene transcription. AIB1 thus plays a dual role in regulating ERalpha activity, one in recruiting transcription factors including other coactivators involved in gene activation and the other in regulating ERalpha protein degradation mediated by the ubiquitin-proteosome machinery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289619      PMCID: PMC511007          DOI: 10.1073/pnas.0402997101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.

Authors:  X Hu; M A Lazar
Journal:  Nature       Date:  1999-11-04       Impact factor: 49.962

2.  Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.

Authors:  C A Lange; T Shen; K B Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development.

Authors:  J Xu; L Liao; G Ning; H Yoshida-Komiya; C Deng; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Comparative analyses of mechanistic differences among antiestrogens.

Authors:  A L Wijayaratne; S C Nagel; L A Paige; D J Christensen; J D Norris; D M Fowlkes; D P McDonnell
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

5.  Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling.

Authors:  George Reid; Michael R Hübner; Raphaël Métivier; Heike Brand; Stefanie Denger; Dominique Manu; Joël Beaudouin; Jan Ellenberg; Frank Gannon
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

6.  The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.

Authors:  D M Lonard; Z Nawaz; C L Smith; B W O'Malley
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

7.  AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor.

Authors:  J Font de Mora; M Brown
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

8.  Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.

Authors:  C Kent Osborne; Valerie Bardou; Torsten A Hopp; Gary C Chamness; Susan G Hilsenbeck; Suzanne A W Fuqua; Jiemin Wong; D Craig Allred; Gary M Clark; Rachel Schiff
Journal:  J Natl Cancer Inst       Date:  2003-03-05       Impact factor: 13.506

9.  Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique.

Authors:  R L Eckert; A Mullick; E A Rorke; B S Katzenellenbogen
Journal:  Endocrinology       Date:  1984-02       Impact factor: 4.736

10.  Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter.

Authors:  Raphaël Métivier; Graziella Penot; Michael R Hübner; George Reid; Heike Brand; Martin Kos; Frank Gannon
Journal:  Cell       Date:  2003-12-12       Impact factor: 41.582

View more
  51 in total

1.  Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity.

Authors:  Larbi Amazit; Audrey Roseau; Junaid A Khan; Anne Chauchereau; Rakesh K Tyagi; Hugues Loosfelt; Philippe Leclerc; Marc Lombès; Anne Guiochon-Mantel
Journal:  Mol Endocrinol       Date:  2011-01-27

2.  ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells.

Authors:  Xue-Yuan Dong; Xiaodong Sun; Peng Guo; Qunna Li; Masakiyo Sasahara; Yoko Ishii; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

3.  O-GlcNAc integrates the proteasome and transcriptome to regulate nuclear hormone receptors.

Authors:  Damon B Bowe; Andrea Sadlonova; Clifford A Toleman; Zdenek Novak; Yong Hu; Ping Huang; Shibani Mukherjee; Timothy Whitsett; Andra R Frost; Andrew J Paterson; Jeffrey E Kudlow
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

4.  Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus.

Authors:  Christopher C Valley; Raphaël Métivier; Natalia M Solodin; Amy M Fowler; Mara T Mashek; Lindsay Hill; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 5.  Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy.

Authors:  Wen Zhou; Joyce M Slingerland
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

6.  Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer.

Authors:  Xin Pan; Tao Zhou; Yan-Hong Tai; Chenguang Wang; Jie Zhao; Yuan Cao; Yuan Chen; Pei-Jing Zhang; Ming Yu; Cheng Zhen; Rui Mu; Zhao-Fang Bai; Hui-Yan Li; Ai-Ling Li; Bing Liang; Zhao Jian; Wei-Na Zhang; Jiang-Hong Man; Yan-Fei Gao; Wei-Li Gong; Li-Xin Wei; Xue-Min Zhang
Journal:  Nat Med       Date:  2011-05-15       Impact factor: 53.440

7.  Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity.

Authors:  Maggie C Louie; Alexey S Revenko; June X Zou; Jennifer Yao; Hong-Wu Chen
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

8.  27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.

Authors:  Carolyn D DuSell; Michihisa Umetani; Philip W Shaul; David J Mangelsdorf; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2007-09-13

9.  Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells.

Authors:  Shubin Sheng; Daniel H Barnett; Benita S Katzenellenbogen
Journal:  Mol Cell Endocrinol       Date:  2008-10-04       Impact factor: 4.102

10.  SUG-1 plays proteolytic and non-proteolytic roles in the control of retinoic acid target genes via its interaction with SRC-3.

Authors:  Christine Ferry; Maurizio Gianni; Sébastien Lalevée; Nathalie Bruck; Jean-Luc Plassat; Ivan Raska; Enrico Garattini; Cécile Rochette-Egly
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.